Global Lipid Disorder Treatment Market to Reach $44.4 Billion by 2030
The global market for Lipid Disorder Treatment estimated at US$29.2 Billion in the year 2023, is expected to reach US$44.4 Billion by 2030, growing at a CAGR of 6.2% over the period 2023-2030.
The U.S. Market is Estimated at $7.7 Billion, While China is Forecast to Grow at 9.2% CAGR
The Lipid Disorder Treatment market in the U.S. is estimated at US$7.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.3 Billion by the year 2030 trailing a CAGR of 9.2% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.2% and 5.7% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook